Exelixis Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Exelixis
EXEL Stock  USD 43.95  0.05  0.11%   
Exelixis' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Exelixis' valuation are provided below:
Gross Profit
2.2 B
Profit Margin
0.2963
Market Capitalization
11.8 B
Enterprise Value Revenue
4.7889
Revenue
2.3 B
There are over one hundred nineteen available fundamental signals for Exelixis, which can be analyzed over time and compared to other ratios. We recommend to verify Exelixis' prevailing fundamental drivers against the all of the trends between 2010 and 2026. Market Cap is expected to rise to about 7.2 B this year. Enterprise Value is expected to rise to about 7.1 B this year

Exelixis Total Revenue

2.62 Billion

Check Exelixis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Exelixis' main balance sheet or income statement drivers, such as Interest Expense of 64.9 M, Total Revenue of 2.6 B or Gross Profit of 2.5 B, as well as many indicators such as Price To Sales Ratio of 3.96, Dividend Yield of 0.0 or PTB Ratio of 3.89. Exelixis financial statements analysis is a perfect complement when working with Exelixis Valuation or Volatility modules.
  
Build AI portfolio with Exelixis Stock
Check out the analysis of Exelixis Correlation against competitors.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

Exelixis Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.6 B3.4 B1.6 B
Slightly volatile
Common Stock Shares Outstanding184.2 M340.6 M246 M
Slightly volatile
Liabilities And Stockholders Equity3.6 B3.4 B1.6 B
Slightly volatile
Other Stockholder Equity1.5 B2.7 B1.9 B
Slightly volatile
Short and Long Term Debt Total180.8 M219.4 M204.7 M
Pretty Stable
Other Current Liabilities441.4 M420.4 M167.5 M
Slightly volatile
Total Current Liabilities487.6 M464.3 M220.3 M
Slightly volatile
Property Plant And Equipment Net433.6 M413 M141.3 M
Slightly volatile
Accounts Payable46.1 M43.9 M18.4 M
Slightly volatile
Cash192.8 M250 M228.4 M
Slightly volatile
Non Current Assets Total1.8 B1.7 B719.5 M
Slightly volatile
Non Currrent Assets Other28.7 M32 M33.9 M
Slightly volatile
Cash And Short Term Investments1.3 B1.3 B719.3 M
Slightly volatile
Net Receivables320.5 M305.3 M132.6 M
Slightly volatile
Short Term Investments1.1 B1 B486.8 M
Slightly volatile
Non Current Liabilities Total217.6 M344.7 M216.3 M
Very volatile
Other Current Assets82.7 M78.7 M34.8 M
Slightly volatile
Total Liabilities849.5 M809 M445.1 M
Slightly volatile
Total Current Assets1.8 B1.7 B899.4 M
Slightly volatile
Short Term Debt49.5 M28.8 M59.6 M
Pretty Stable
Common Stock241.1 K253.8 K1.4 M
Slightly volatile
Other Liabilities83.4 M78.8 M57.7 M
Pretty Stable
Other Assets346.4 M329.9 M145 M
Slightly volatile
Good Will51.2 M57.3 M62 M
Pretty Stable
Common Stock Total Equity391.2 K372.6 K254 K
Slightly volatile
Property Plant And Equipment Gross555.3 M528.8 M176 M
Slightly volatile
Intangible Assets64.2 M73.2 M64 M
Slightly volatile
Property Plant Equipment133.6 M127.2 M58.2 M
Slightly volatile
Current Deferred Revenue2.3 M2.5 M11.7 M
Slightly volatile
Long Term Debt Total67.5 K71.1 K99.1 M
Slightly volatile
Capital Surpluse2.1 B2.9 B2.1 B
Slightly volatile
Long Term Investments769.5 M732.9 M341.4 M
Slightly volatile
Non Current Liabilities Other131.5 M125.2 M55 M
Slightly volatile
Short and Long Term Debt2.3 M2.5 M65.9 M
Slightly volatile
Net Invested Capital2 B2.6 B1.2 B
Slightly volatile
Net Working Capital1.1 B1.2 B762.8 M
Slightly volatile
Capital Lease Obligations115.4 M219.4 M68.6 M
Slightly volatile
Capital Stock245.1 K253.8 K296.7 K
Slightly volatile

Exelixis Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue2.6 B2.5 B943.7 M
Slightly volatile
Gross Profit2.5 B2.4 B910.6 M
Slightly volatile
Other Operating Expenses1.9 B1.8 B756.7 M
Slightly volatile
Research Development1.1 B1 B454.3 M
Slightly volatile
Total Operating Expenses1.8 B1.7 B723.5 M
Slightly volatile
Depreciation And Amortization27.2 M25.9 M11.5 M
Slightly volatile
Selling General Administrative594.2 M565.9 M253.1 M
Slightly volatile
Interest Income93.2 M88.7 M28.3 M
Slightly volatile
Selling And Marketing Expenses28.3 M46 M20.8 M
Slightly volatile
Reconciled Depreciation34.8 M33.1 M11.2 M
Slightly volatile

Exelixis Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow184.4 M302.4 M225.4 M
Slightly volatile
Depreciation27.2 M25.9 M11.5 M
Slightly volatile
Capital Expenditures79.9 M76.1 M41.1 M
Slightly volatile
End Period Cash Flow193.7 M250 M229.8 M
Slightly volatile
Stock Based Compensation113.3 M107.9 M57 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.964.170310.7553
Slightly volatile
Days Sales Outstanding33.4347.346351.8554
Very volatile
Stock Based Compensation To Revenue0.05520.05810.1411
Slightly volatile
Capex To Depreciation6.656.3373.8674
Slightly volatile
EV To Sales3.924.130312.3729
Slightly volatile
Inventory Turnover4.44.18792.5877
Slightly volatile
Days Of Inventory On Hand82.887.1558208
Slightly volatile
Payables Turnover2.262.14841.7012
Slightly volatile
Sales General And Administrative To Revenue0.280.29650.5585
Slightly volatile
Research And Ddevelopement To Revenue0.540.57051.4416
Slightly volatile
Capex To Revenue0.130.0890.047
Slightly volatile
Cash Per Share2.063.12842.5725
Slightly volatile
Days Payables Outstanding161170442
Slightly volatile
Intangibles To Total Assets0.02060.02160.0722
Slightly volatile
Current Ratio2.93.34274.1812
Pretty Stable
Receivables Turnover7.327.70927.5638
Slightly volatile
Graham Number7.8910.225212.5274
Slightly volatile
Capex Per Share0.540.51220.1781
Slightly volatile
Revenue Per Share6.045.75263.3361
Slightly volatile
Interest Debt Per Share0.570.5970.8985
Slightly volatile
Debt To Assets0.06130.06460.2746
Slightly volatile
Operating Cycle128135248
Pretty Stable
Days Of Payables Outstanding161170442
Slightly volatile
Ebt Per Ebit0.921.5071.2357
Very volatile
Long Term Debt To Capitalization1.31.241.2612
Slightly volatile
Total Debt To Capitalization0.06490.07740.3614
Slightly volatile
Quick Ratio2.873.29884.1303
Pretty Stable
Net Income Per E B T1.050.80680.9214
Pretty Stable
Cash Ratio1.020.6671.3355
Very volatile
Days Of Inventory Outstanding82.887.1558208
Slightly volatile
Days Of Sales Outstanding33.4347.346351.8554
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.490.51110.8494
Slightly volatile
Fixed Asset Turnover3.693.88716.2881
Slightly volatile
Debt Ratio0.06130.06460.2746
Slightly volatile
Price Sales Ratio3.964.170310.7553
Slightly volatile
Asset Turnover0.650.6220.4752
Slightly volatile
Gross Profit Margin1.140.96040.968
Slightly volatile

Exelixis Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap7.2 B6.9 B5.5 B
Slightly volatile
Enterprise Value7.1 B6.8 B5.4 B
Slightly volatile

Exelixis Fundamental Market Drivers

Forward Price Earnings14.1643
Cash And Short Term Investments1.1 B

Exelixis Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Exelixis Financial Statements

Exelixis investors utilize fundamental indicators, such as revenue or net income, to predict how Exelixis Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.5 M2.3 M
Total Revenue2.5 B2.6 B
Cost Of Revenue68.6 M55.7 M
Stock Based Compensation To Revenue 0.06  0.06 
Sales General And Administrative To Revenue 0.30  0.28 
Research And Ddevelopement To Revenue 0.57  0.54 
Capex To Revenue 0.09  0.13 
Revenue Per Share 5.75  6.04 
Ebit Per Revenue 0.09  0.10 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:
How To Invest In Exelixis
Details
Is Exelixis Stock a good investment?
Details
What is Exelixis' Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Exelixis Correlation against competitors.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. Projected growth potential of Exelixis fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Exelixis assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
0.725
Earnings Share
2.38
Revenue Per Share
8.288
Quarterly Revenue Growth
0.108
Return On Assets
0.1773
Investors evaluate Exelixis using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Exelixis' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Exelixis' market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Exelixis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Exelixis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Exelixis' market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY